The effect of food on the absorption and pharmacokinetics of rivaroxaban

耐受性 拜瑞妥 药代动力学 生物利用度 医学 药理学 不利影响 内科学 华法林 心房颤动
作者
Jan Stampfuss,Dagmar Kubitza,Michael Becka,Wolfgang Mueck
出处
期刊:International Journal of Clinical Pharmacology and Therapeutics [Dustri-Verlag]
卷期号:51 (07): 549-561 被引量:200
标识
DOI:10.5414/cp201812
摘要

Doses of 10 mg, 15 mg, and 20 mg of rivaroxaban are approved for the treatment and prevention of thromboembolic disorders in adult patients. In six Phase I studies, the pharmacokinetics, safety, and tolerability of 2.5 mg, 5 mg, 10 mg, 15 mg, and 20 mg rivaroxaban were investigated in healthy male subjects, and the influence of food on these parameters was investigated for the 10 mg, 15 mg, and 20 mg tablet doses. In addition, an oral suspension containing 1 mg/ml rivaroxaban, which is under investigation for future use in the pediatric population, was investigated at doses of 10 mg and 20 mg.Rivaroxaban was obtained from Bayer Pharma AG, Wuppertal, Germany.Six independent, single-dose, cross-over studies were performed in healthy male subjects (between 13 and 24 subjects were enrolled in each study) to determine the pharmacokinetics, safety, and tolerability of rivaroxaban under fasting and fed conditions. Study 1 was an absolute bioavailability study that compared 5 mg and 20 mg tablet doses with a 1 mg intravenous solution. Studies 2 and 3 were confirmatory food-effect studies that assessed 10 mg and 20 mg tablet doses, respectively, under fed and fasting conditions. Study 4 was a formulation study that evaluated oral suspensions of 10 mg (fasting) and 20 mg (fasting and fed) rivaroxaban vs. a 10 mg tablet (fasted). Study 5 was a dose-proportionality study that assessed 2.5 mg, 5 mg, and 10 mg tablets under fasting conditions. Study 6 was a dose-proportionality study that assessed tablet doses of 10 mg, 15 mg, and 20 mg under fed conditions. Pharmacokinetic parameters, including the area under the plasma concentration-time curve after a single dose, the maximum drug concentration in plasma after a single dose, dose-adjusted values of area under the plasma concentration-time curve and maximum drug concentration in plasma after a single dose, half-life associated with the terminal slope, and time to maximum concentration in plasma after a single dose were evaluated. Adverse events were classified according to their degree of severity and were summarized using Medical Dictionary for Regulatory Activities preferred terms.At all doses, rivaroxaban showed an acceptable safety profile and was well tolerated in healthy individuals. Independent of food and formulation, pharmacokinetic parameters of doses up to 10 mg rivaroxaban were dose proportional and had high oral bioavailability (≥ 80%). Under fasting conditions, pharmacokinetic parameters of 15 mg and 20 mg rivaroxaban increased with dose but were less than dose proportional. However, when taken with food, high bioavailability (≥ 80%) of these doses was achieved independent of formulation.Pharmacokinetic parameters of doses up to 10 mg rivaroxaban were dose proportional and had high oral bioavailability independent of food or whether administered as tablet or solution. High bioavailability (≥ 80%) of 15 mg and 20 mg rivaroxaban was achieved when taken with food; therefore, these doses need to be taken with food.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
keyby发布了新的文献求助10
1秒前
FashionBoy应助xdc采纳,获得10
6秒前
杨召完成签到,获得积分10
11秒前
大橙子发布了新的文献求助10
15秒前
酷波er应助陈昊采纳,获得10
19秒前
hcsdgf完成签到 ,获得积分10
21秒前
可取完成签到,获得积分10
22秒前
zss完成签到 ,获得积分10
22秒前
23秒前
heart完成签到 ,获得积分10
25秒前
26秒前
lingyu完成签到,获得积分10
27秒前
ym完成签到 ,获得积分10
28秒前
Masetti1完成签到 ,获得积分10
30秒前
jenny发布了新的文献求助10
31秒前
忧虑的静柏完成签到 ,获得积分10
32秒前
32秒前
强公子发布了新的文献求助10
36秒前
自由的远侵完成签到 ,获得积分10
44秒前
巧克力手印完成签到,获得积分10
45秒前
屈岂愈发布了新的文献求助10
45秒前
46秒前
大橙子发布了新的文献求助10
47秒前
量子星尘发布了新的文献求助10
48秒前
jenny完成签到,获得积分10
49秒前
祁乐安完成签到,获得积分10
50秒前
naiyouqiu1989完成签到,获得积分10
51秒前
zjhzslq发布了新的文献求助10
52秒前
baoxiaozhai完成签到 ,获得积分10
53秒前
fy完成签到,获得积分10
54秒前
强公子完成签到,获得积分10
55秒前
1分钟前
song完成签到 ,获得积分10
1分钟前
怡然小蚂蚁完成签到 ,获得积分10
1分钟前
小橙子完成签到,获得积分10
1分钟前
SciGPT应助滴答采纳,获得10
1分钟前
大气白翠完成签到,获得积分10
1分钟前
确幸完成签到,获得积分10
1分钟前
zjhzslq完成签到,获得积分10
1分钟前
xdc发布了新的文献求助10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022